This Month in Laryngoscope
This Month in Laryngoscope
Office-Based Sclerotherapy for Benign Parotid Lymphoepithelial Cysts
Benign lymphoepithelial cysts are frequently encountered in the parotid gland of patients with HIV infection. The authors report the successful use of sodium morrhuate as a sclerosing agent in this population. All cysts were aspirated before approximately 3 cc's of sclerosing agent were introduced. The procedure was effective and well-tolerated. There was no incidence of facial nerve injury. See page 868
The Effect of Bevacizumab (Avastin) Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Patients with hereditary hemmorhagic telangiectasia often suffer from intractable epistaxis. The authors speculate that inhibition of angiogenic factors may help control epistaxis. A prospective pilot study compared a group of patients treated with a KTP laser alone to a second group treated with a KTP laser and Bevacizumab. Clinical outcomes indicated the KTP laser combined with Bevicizumab in HHT epistaxis is superior to treatment with a laser alone. See page 988
Do palatal implants really reduce snoring in long-term follow-up?
The authors report a retrospective review of a group of patients with primary snoring. In each case the apnea-hypopnea index was less than 5. Primary snoring was treated with a palatal implant. Patients were followed for a minimum of 18 months postoperatively. During this time, treatment effectiveness was monitored with a visual analog scale obtained from bed partners to determine the severity of snoring. Successful treatment was observed in most of patients at the 6 month evaluation and this was maintained in 52% of the patients at the 18 months posttreatment. Results observed at the 3-month evaluation were predictive of long-term success. See page 1000
Primary Tumor Thickness as a Risk Factor for Contralateral Cervical Metastases in T1/T2 Oral Tongue Squamous Cell Carcinoma
The authors report a retrospective review of pathologic material obtained from 50 patients that were treated surgically for early oral tongue cancer. Contralateral cervical metastasis were observed in 6 of these patients during therapy or extended follow-up. If the primary tumor thickness was less than 3.75mm, there were no cases of contralateral node metastases. The odds ratio for developing contralateral neck metastases was 5% for each 1mm increase in tumor thickness. This may be useful information in clinical decision-making. See page 883
On the Cover
Current scientific efforts in cochlear implantation focus on preservation of residual hearing. Radeloff et al. show that a coated electrode array reduces the insertion forces related to intracochlear trauma and postoperative hearing loss. The figure shows a crosssection through the cochlea with an electrode array inserted into the scala tympani. Up to the apical turn — where functional hair cells reside in patients with residual hearing — the coating material (asterisks) is visible as a potential drug reservoir. For further reading, please see the article on page 959 by Radeloff et al.